Bruce D. Jackson Analyst PerformanceAnalyst at BenchmarkBruce D. Jackson is a stock analyst at Benchmark in the healthcare sector, covering 13 publicly traded companies. Over the past year, Bruce D. Jackson has issued 25 stock ratings, including buy and hold recommendations. While full access to Bruce D. Jackson's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Bruce D. Jackson's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings25 Last 0 YearsBuy Recommendations96.00% 24 Buy RatingsCompanies Covered13 Unique Companies Ratings Distribution25RatingsDistribution of strong buy, buy, hold, and sell ratings by Bruce D. Jackson.RatingPercentageCount Strong Buy0.0%0 ratings Buy96.0%24 ratings Hold4.0%1 ratings Sell0.0%0 ratingsOut of 25 total stock ratings issued by Bruce D. Jackson at Benchmark, the majority (96.0%) have been Buy recommendations, followed by 4.0% Hold.Best & Worst CallsThis analyst does not have any ratings with enough history to determine best and worst calls.Exchange CoverageExchangePercentageCountNASDAQ84.6% of companies on NASDAQ11 companiesNYSE15.4% of companies on NYSE2 companiesBruce D. Jackson, an analyst at Benchmark, currently covers 13 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare13 companies100.0%Bruce D. Jackson of Benchmark specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageHEALTHCARE EQUIPMENT & SUPPLIES4 companies30.8%PHARMACEUTICALS4 companies30.8%BIOTECHNOLOGY3 companies23.1%LIFE SCIENCES TOOLS & SERVICES1 company7.7%HEALTHCARE PROVIDERS & SERVICES1 company7.7% Bruce D. Jackson's Ratings History at Benchmark Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsGNLXGenelux8/18/2026Reiterated Rating$2.66Speculative Buy$0.0000.00% ROIHUMAHumacyte8/13/2026Lower Price Target$0.66$1.00Speculative Buy$0.0000.00% ROIHBIOHarvard Bioscience8/12/2026Boost Price Target$6.13$7.50Speculative Buy$0.0000.00% ROIPODDInsulet8/6/2026Lower Price Target$136.49$185.00Buy$0.0000.00% ROIDXCMDexCom7/31/2026Boost Price Target$82.27$82.00Buy$0.0000.00% ROINEONeoGenomics7/24/2026Boost Price Target$14.24$16.00Buy$0.0000.00% ROIUNCYUnicycive Therapeutics6/2/2026Reiterated Rating$7.51$18.00Speculative Buy$0.0000.00% ROIHUMAHumacyte6/1/2026Boost Price Target$1.30$2.00Speculative Buy$0.0000.00% ROIABTAbbott Laboratories4/17/2026Lower Price Target$95.08$120.00Buy$0.0000.00% ROIUNCYUnicycive Therapeutics4/6/2026Lower Price Target$6.93$15.00Speculative Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. GNLXGenelux3/20/2026Lower Price Target$2.41$20.00Speculative Buy$0.0000.00% ROIHBIOHarvard Bioscience3/13/2026Lower Price Target$4.94$6.00Speculative Buy$0.0000.00% ROIBLTEBelite Bio3/3/2026Reiterated Rating$176.17Buy$0.0000.00% ROIHUMAHumacyte1/21/2026Lower Price Target$1.04$10.00Buy$0.0000.00% ROICLNNClene12/4/2025Reiterated Rating$6.68Buy$0.0000.00% ROIBLTEBelite Bio12/3/2025Reiterated Rating$153.69Buy$0.0000.00% ROIEXASExact Sciences11/24/2025Downgrade$100.90Hold$0.0000.00% ROIMLSSMilestone Scientific11/20/2025Lower Price Target$0.32$1.00Speculative Buy$0.0000.00% ROIHUMAHumacyte11/13/2025Lower Price Target$1.19$11.00Buy$0.0000.00% ROIEXASExact Sciences11/4/2025Boost Price Target$70.21$75.00Buy$0.0000.00% ROIBLTEBelite Bio10/31/2025Boost Price Target$98.93$132.00Buy$0.0000.00% ROIRVPHReviva Pharmaceuticals9/15/2025Lower Price Target$8.85$140.00Speculative Buy$0.0000.00% ROIUNCYUnicycive Therapeutics9/15/2025Boost Price Target$3.87$21.00Speculative Buy$0.0000.00% ROIHBIOHarvard Bioscience9/10/2025Lower Price Target$4.38$20.00Speculative Buy$0.0000.00% ROICLNNClene9/10/2025Lower Price Target$6.60$31.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenThe Goldman Sachs GroupCICC ResearchWeiss RatingsCitigroupUBS GroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupTD CowenTruist FinancialPiper Sandler Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
